Tectonic Therapeutic, Inc.

Healthcare · Biotechnology · United States

Last price 19.56 USD (Oct 30, 2026, 1:42 PM EDT) · Market cap 382.39M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPC...